Download the entire issue - American Association for Clinical ...

special section
Advertisement
OSOM® C. difficile Toxin A/B Test*
OSOM C. difficile Toxin A/B is a rapid test to
aid in the diagnosis of C. difficile infection.
The assay requires just four simple steps, and
results are available in 20 minutes or less. No
incubation is required, and labs can run the
test in batch or STAT. An accurate, easy-toread,
two-color dipstick provides clear objective
results. Each kit contains all the materials
necessary to run the test, plus two additional
test sticks for external QC. Online training
is available anytime at www.osomtraining.
com. *Made in the U.S.
Sekisui Diagnostics, LLC
www.sekisuidiagnostics.com
Booth No. 2705
Clostridium difficile
Immunochromatographic Test*
A-B diff is a rapid immunochromatographic
test for Clostridium difficile detection. Its
main innovations compared to other tests
in the market are detection of toxin A and
toxin B in independent bands. This fact is
important for making treatment decisions
and isolating infected patients. It’s extremely
quick, 10 minutes for sample preparation
plus 15 minutes for reading results. It’s a
very easy procedure, and it does not require
special equipment, merely dissolve the stool
sample in a buffer and add a quantity of the
supernatant to the strip. HYPER diff is a
rapid immunochromatographic test that can
detect suspected hypervirulent strains of C.
difficile as the ribotypes O27 or O17. *Available
for sale outside the U.S.
OPERON, S.A.
www.operon.es
Booth No. 1943
Chagas Disease Detection kits*
Wiener Labs has a complete line of kits for
detection of Chagas disease, a parasitic infection
produced by Trypanosoma cruzi. Commonly,
the disease evolves towards a chronic
phase. During the acute phase, the diagnosis
is performed by detection of parasites in
blood. During the chronic phase, serologic
methods are used as screening tests. Today,
blood donations in all endemic Latin American
countries undergo Chagas screening, and
22 CliniCal laboratory news July 2011
2 0 11 N E w P r o d U c T s r E v I E w
testing is expanding to other countries like
the U.S. The line is composed of: Chagatest
ELISA recombinante v.4.0®, Chagatest ELISA
recombinante v.3.0®, Chagatest ELISA lisado®,
WL Check Chagas®, Chagatest HAI®,
Chagatest HAI A-V®. *For research use only.
Wiener Laboratories SAIC
www.wiener-lab.com.ar
Booth No. 3670
iRICELL®pro Automated urinalysis System
The iRICELL pro consists of the iQ®200
Series Automated Urine Microscopy analyzer
and the iCHEM®VELOCITY Automated
Urine Chemistry analyzer with iWARE®
Integrated Urinalysis Software.
Iris Diagnostics,
a division of IRIS International, Inc.
www.irisdiagnostics.com
Booth No. 419
BioCode-HP Analyzer*
Barcoded Magnetic Beads (BMBs), a digital
multiplex platform, are encoded with a high-
contrast pattern that simplifies multiplexed
diagnostic and molecular diagnostic assays
while offering high throughput, high accuracy,
and cost savings. Each bead contains
one of 4,096 digital barcodes. Up to 4,096
immunoassay or nucleic acid analytes/
sample can be tested simultaneously in a
96-microwell plate. Biocode-HP Analyzer
rapidly scans the BMBs, decodes the barcode,
detects label fluorescence, and displays the
results. The system provides a wide variety
of applications, including infectious diseases,
cancer diagnostics, HLA, autoimmune, companion
diagnostics, gene expression analysis,
micro RNA, genetic testing, and biomarker
validation. *For research use only.
Applied BioCode, Inc.
www.ApBioCode.com
Booth No. 2573
MINICAP FLEx Piercing:
Whole-Blood Hb Testing*
Whole-blood hemoglobinopathy testing by
capillary electrophoresis (CE) with cappiercing
capabilities is now available with the
MINICAP FLEX Piercing instrument. The
MINICAP FLEX Piercing system with its
small footprint is designed to optimize and
completely automate electrophoresis testing
in low- to medium-volume laboratories.
Simply place a barcoded primary tube
on the system and walk away; the whole
blood plasma samples are automatically
inverted prior to analysis and a continuous
access sample wheel allows for addition of
samples at any time. True positive sample
ID is achieved with full traceability. A
complete test menu is available, including:
protein electrophoresis, immunotyping,
and CDT (chronic alcohol abuse marker).
*Pending FDA clearance. Available for sale
outside the U.S.
Sebia Electrophoresis
www.sebia-usa.com
Booth No. 3111
CAPILLARYS 2 FLEx Piercing:
Whole-Blood Hb Testing*
Whole-blood hemoglobinopathy testing by
capillary electrophoresis (CE) with cappiercing
capabilities is now available with
the CAPILLARYS 2 FLEX Piercing system.
Whole-blood plasma samples are automatically
inverted before sampling to ensure
thorough homogenization of the sample and
accurate Hb results. A high-resolution Hb
separation takes place concurrently in eight
capillaries with a sample throughput of 37
results per hour. CAPILLARYS 2 FLEX Piercing
is a continuous-feed system that provides
full traceability from bar-coded primary
sample tube to final result. A complete test
menu is available, including serum and urine
protein electrophoresis; immunotyping; and
CDT (chronic alcohol abuse marker). *Pending
FDA clearance. Available for sale outside
the U.S.
Sebia Electrophoresis
www.sebia-usa.com
Booth No. 3111
Tumor Marker Control*
Fujirebio Diagnostics, Inc., the industry
leader in biomarker assays, presents its solution
for accurate precision monitoring of
laboratory tumor marker assays. The Tumor
Marker Control is intended for use as a
quantitative, assayed serum control. This
is the only multi-constituent control to
contain the novel biomarker HE4 used to
monitor progression and recurrence of
epithelial ovarian carcinoma. It contains
clinically relevant proportions of free
PSA and PSA-ACT. Analytes include AFP,
CA 15-3, CA 19-9, CA 125, CEA, ferritin,
HE4, total PSA, and free PSA. Reconstituted,
open-vial stability is 14 days at 2–8ºC
with the following exception: Free PSA is
stable for 7 days. The control sustains nine
freeze/thaw cycles at ≤–20ºC. *Available
for sale outside the U.S.
Fujirebio Diagnostics, Inc.
www.fdimcc.com
Booth No. 2221
EncompassMDx*
Rheonix® introduces an automated microfluidic
platform for the evolving molecular
diagnostics industry. Rheonix CARD®
technology automatically processes samples
through purification, multiplexed amplification,
and endpoint detection, offering true
sample-to-result functionality with minimal
technician hands-on time. The versatile
system can be rapidly customized for a broad
spectrum of diagnostic applications and incorporates
low-cost consumables to analyze
raw clinical samples such as blood, saliva,
buccal and vaginal swabs. Successful pilot
programs have applied a range of functional
assays to the EncompassMDx platform,
including SNP detection, pathogen identification,
immunoassays, cell-based assays, and
other molecular diagnostic applications. *For
research use only.
Rheonix, Inc.
www.rheonix.com
Booth No. 4434
Chemiluminescence Immunoassay for TB*
The Anti-TB kit is a chemiluminescence immunoassay
(CLIA) test for detecting specific
antibodies to Mycobacterium tuberculosis
(TB) in human serum or plasma. In conjunction
with Chemclin®100, a semi-automated
CLIA analyzer, and Chemclin®600, a
fully automated CLIA instrument, this assay
provides high throughput and reliable detection.
This assay offers laboratories higher
sensitivity and is more user-friendly than
other ELISA and RIA-based anti-TB assays.
*Available for sale outside the U.S.
Beijing Chemclin Biotech Co., Ltd.
www.chemclin.com
Booth No. 3952
ARCHITECT HIV Ag/Ab Combo Assay*
ARCHITECT HIV Ag/Ab Combo assay is a
chemiluminescent microparticle immunoassay
for simultaneous qualitative detection
of human immunodeficiency virus (HIV)
p24 antigen and antibodies to HIV type 1